Cargando…

Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study

BACKGROUND: Chronic hepatitis B has become a major public health problem in China. An accurate depiction of the disease burden has not yet been thoroughly conducted. We aimed to project the disease burden of chronic hepatitis B virus (HBV) infection and related complications by modeling various scen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yang, Wu, Jie, Ding, Cheng, Xu, Kaijin, Yang, Shigui, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455911/ https://www.ncbi.nlm.nih.gov/pubmed/32859216 http://dx.doi.org/10.1186/s12985-020-01393-z

Ejemplares similares

Projected burden of stroke in China through 2050
por: Yao, Minghong, et al.
Publicado: (2023)

Projections of the economic burden of care for individuals with dementia in mainland China from 2010 to 2050
por: Huang, Yixiang, et al.
Publicado: (2022)

Prevalence and Incidence of Non-alcohol Fatty Liver Disease in Chronic Hepatitis B Population in Southeast China: A Community-Based Study
por: Zheng, Yang, et al.
Publicado: (2021)

Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China
por: Yang, Shigui, et al.
Publicado: (2015)

Incidence and Influencing Factors of New Hepatitis B Infections and Spontaneous Clearance: A Large-Scale, Community-Based Study in China
por: Hu, Haiyang, et al.
Publicado: (2021)

Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases
por: Ding, Cheng, et al.
Publicado: (2019)

Projecting the spatiotemporal carbon dynamics of the Greater Yellowstone Ecosystem from 2006 to 2050
por: Huang, Shengli, et al.
Publicado: (2015)

Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study
por: Clay, Emilie, et al.
Publicado: (2019)

Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China
por: Wu, Wei, et al.
Publicado: (2017)

Prevalence and influencing factors of hepatitis B among a rural residential population in Zhejiang Province, China: a cross-sectional study
por: Yang, Shigui, et al.
Publicado: (2017)

Prevalence of Hepatitis B in Insular Regions of Southeast China: A Community-Based Study
por: Chen, Ping, et al.
Publicado: (2013)

Pancreatitis, Pancreatic Cancer, and Their Metabolic Sequelae: Projected Burden to 2050
por: Cho, Jaelim, et al.
Publicado: (2020)

Global burden and drivers of hyperglycemia: Estimates and predictions from 1990 to 2050
por: Qiu, Hui-Ling, et al.
Publicado: (2023)

Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study
por: Yang, Shigui, et al.
Publicado: (2017)

Trends and Challenges for Population Health and Migration — China, 2015−2050
por: Luo, Yanan, et al.
Publicado: (2020)

Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis
por: Jiang, Daixi, et al.
Publicado: (2021)

Nasopharyngeal Carcinoma Burden and Its Attributable Risk Factors in China: Estimates and Forecasts from 1990 to 2050
por: Zhang, Ruhao, et al.
Publicado: (2023)

The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
por: Hodgson, J T, et al.
Publicado: (2005)

Factors influencing immunologic response to hepatitis B vaccine in adults
por: Yang, Shigui, et al.
Publicado: (2016)

Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study
por: Chen, Ping, et al.
Publicado: (2013)

Estimating the Incidence of Tuberculosis — Shanghai, China, 2025−2050
por: Yu, Shegen, et al.
Publicado: (2020)

Projected burden of type 2 diabetes mellitus-related complications in Singapore until 2050: a Bayesian evidence synthesis
por: Tan, Ken Wei, et al.
Publicado: (2020)

Performance of Biochip system in detecting drug resistant and multidrug-resistant tuberculosis using sputum collected from multiple clinical settings in Zhejiang, China
por: Xu, Kaijin, et al.
Publicado: (2018)

Regional energy 2050
por: Herrmann, Nicolai
Publicado: (2011)

Desarrollo Industrial 2050/
por: Oropeza García Arturo

Psychological stress; knowledge, attitude and practice and acceptance of antiviral therapy in pregnant women with hepatitis B in Zhejiang, China: a case comparison study
por: Liu, Xiaoxiao, et al.
Publicado: (2022)

Prospective contributions of biomass pyrolysis to China’s 2050 carbon reduction and renewable energy goals
por: Yang, Qing, et al.
Publicado: (2021)

Disease burden in Norway in 2050: A forecasting analysis based on the Global Burden of Disease (GBD) Study
por: Knudsen, A K, et al.
Publicado: (2023)

Trends and Challenges for Population and Health During Population Aging — China, 2015–2050
por: Luo, Yanan, et al.
Publicado: (2021)

Age of Retirement and Human Capital in an Aging China, 2015–2050
por: Feng, Qiushi, et al.
Publicado: (2018)

Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
por: Xu, Kaijin, et al.
Publicado: (2014)

A unified physics by 2050?
por: Weinberg, Steven
Publicado: (2003)

Fusion - 2050 perspective (in Polish)
por: Romaniuk, R S
Publicado: (2013)

Contact network analysis of COVID-19 Delta variant outbreak in urban China —based on 2,050 confirmed cases in Xi’an, China
por: Zhangbo, Yang, et al.
Publicado: (2022)

Simulating Land-Use Changes and Predicting Maize Potential Yields in Northeast China for 2050
por: Pu, Luoman, et al.
Publicado: (2021)

Exploring China stepping into the dawn of chemical pesticide-free agriculture in 2050
por: Wang, Xuejiang, et al.
Publicado: (2022)

Transmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-Analysis
por: Yang, Shigui, et al.
Publicado: (2015)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Predictors of inflammatory activity in treatment-naive hepatitis B e-antigen-negative patients with chronic hepatitis B infection
por: Hu, Jianhua, et al.
Publicado: (2020)

Malaria in China: a longitudinal population-based surveillance study
por: Ding, Cheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fto526clph8ve3jlg5p3splvcp